How to Get Rapamycin (Sirolimus) in Nebraska

What Is Rapamycin and Why Are Nebraskans Seeking It?

Rapamycin (sirolimus) is an mTOR inhibitor originally approved by the FDA in 1999 for the prevention of organ transplant rejection [1]. Over the past decade, a growing body of preclinical and early clinical evidence has positioned low-dose, intermittent rapamycin as a candidate geroprotective agent. The PEARL trial (Participatory Evaluation of Aging with Rapamycin for Longevity), published in Aging Cell in 2024 (N=150), found that 5 mg weekly sirolimus was well tolerated in healthy adults aged 50 to 85 over 12 months, with no significant increase in infections compared to placebo [2].

Why Nebraska Specifically?

Nebraska has a regulatory environment that supports telehealth prescribing, full practice authority for nurse practitioners, and a network of 503A compounding pharmacies. These three factors make it relatively straightforward for residents in both Omaha and rural western counties to access sirolimus without traveling out of state. Interest in rapamycin among Nebraska patients has followed the national trend: Google Trends data show a 340% increase in searches for "rapamycin longevity" between January 2022 and January 2026.

Off-Label vs. On-Label Use

The FDA-approved indication is transplant rejection prophylaxis, typically dosed at 2 mg daily after a 6 mg loading dose in renal transplant recipients [1]. Off-label longevity prescribing uses a different regimen: 3 to 6 mg once weekly, sometimes with periodic "drug holidays" of 2 to 4 weeks. The Endocrine Society and the American Federation for Aging Research have not yet issued formal guidelines for geroprotective rapamycin use, so prescribers rely on emerging trial data and expert consensus.

Who Can Prescribe Rapamycin in Nebraska?

Any Nebraska-licensed prescriber with the appropriate scope of practice can write a sirolimus prescription. That includes physicians (MD/DO), nurse practitioners (APRN-NP), and physician assistants (PA-C). Nebraska grants full practice authority to APRNs under the Nebraska Nurse Practice Act, meaning NPs do not need a collaborative physician agreement to prescribe [3].

Prescriber Requirements

A prescriber must establish a valid provider-patient relationship before writing the prescription. Under Nebraska's telehealth statute (LB 400, enacted 2017), this relationship can be established via a synchronous audio-video visit. An asynchronous (store-and-forward) encounter alone is not sufficient for initial prescribing of a new medication.

What to Expect at Your Appointment

Expect the prescriber to review your medical history, current medications, and goals for rapamycin use. They will order baseline laboratory work (detailed below) and discuss potential side effects including mouth sores, lipid elevations, and mild immunosuppression. The American Society of Transplantation notes that "sirolimus-related mucositis occurs in approximately 20 to 60% of transplant patients at full immunosuppressive doses but is substantially less common at low intermittent doses" [4].

Telehealth Access for Nebraska Residents

Nebraska law explicitly permits prescribing via telehealth, and several national telehealth platforms now include rapamycin in their formularies. A telehealth visit eliminates the need to drive to Omaha or Lincoln for an in-person consultation, which matters in a state where 83 of 93 counties are classified as rural by the U.S. Census Bureau.

How a Telehealth Visit Works

The process typically follows four steps. First, you complete an online intake form with your health history, medications, and reason for seeking sirolimus. Second, a licensed prescriber (credentialed in Nebraska) conducts a live video consultation lasting 15 to 30 minutes. Third, the prescriber orders labs, which you complete at a local draw site (Quest Diagnostics and Labcorp both operate collection centers across Nebraska). Fourth, once lab results confirm eligibility, the prescriber sends the prescription to a pharmacy of your choice.

Choosing a Telehealth Provider

Look for providers who meet three criteria: (1) they are licensed in Nebraska or hold a compact license recognized by the state, (2) they order and review labs before prescribing, and (3) they provide ongoing monitoring at defined intervals (typically every 3 to 6 months). Platforms that skip lab work or prescribe rapamycin on a first-visit questionnaire alone should raise concern.

Required Labs Before Starting Rapamycin in Nebraska

Lab work is non-negotiable. Rapamycin can raise LDL cholesterol by 15 to 30%, raise triglycerides, and suppress white blood cell counts at higher doses [5]. Baseline labs give the prescriber a reference point for monitoring.

Baseline Panel

The standard pre-rapamycin panel includes:

| Test | Why It Matters | |---|---| | CBC with differential | Detects baseline leukopenia or thrombocytopenia | | CMP (comprehensive metabolic panel) | Assesses liver and kidney function | | Fasting lipid panel | Documents pre-treatment LDL, HDL, triglycerides | | Fasting glucose or HbA1c | Screens for pre-diabetes or diabetes | | Sirolimus trough level (if switching doses) | Confirms drug clearance from prior dosing |

Follow-Up Lab Schedule

Most prescribers order a repeat CBC, CMP, and fasting lipid panel at 4 to 6 weeks after initiation, then every 3 to 6 months. A sirolimus trough level is not always necessary for weekly off-label dosing because trough concentrations on a once-weekly schedule fall well below the 5 to 15 ng/mL therapeutic range used in transplant medicine. The PEARL trial measured trough levels at week 4 and week 48, finding mean troughs of 2.0 ng/mL at the 5 mg weekly dose [2].

Where to Get Labs Drawn

Quest Diagnostics operates 14 patient service centers in Nebraska, concentrated in Omaha, Lincoln, and Grand Island. Labcorp has 6 locations. Many telehealth platforms also partner with mobile phlebotomy services that come to your home, a useful option for patients in Scottsbluff, North Platte, or other western Nebraska cities.

503A Compounding Pharmacies in Nebraska

Nebraska's Board of Pharmacy licenses 503A compounding pharmacies under the state's Pharmacy Practice Act. A 503A pharmacy compounds medications in response to an individual patient prescription, as opposed to 503B outsourcing facilities that manufacture in bulk without patient-specific prescriptions. Both types can legally compound sirolimus, but the 503A route is more common for off-label longevity patients.

How 503A Compounding Works

A prescriber sends a prescription specifying the dose (e.g., 5 mg capsule) and quantity. The pharmacy compounds the capsules using USP-grade sirolimus powder and ships them directly to the patient. Turnaround time is typically 5 to 10 business days. Shipping within Nebraska is permitted; shipping across state lines requires the pharmacy to also be licensed in the destination state.

Cost Expectations

Compounded sirolimus capsules generally cost $2 to $4 per capsule at off-label longevity doses (3 to 6 mg). A 12-week supply of once-weekly dosing (12 capsules) runs approximately $24 to $48 out of pocket. Generic Rapamune tablets (1 mg and 2 mg) from commercial pharmacies cost more per milligram, with GoodRx reporting a cash price of $90 to $180 for 30 tablets of 1 mg generic sirolimus at Nebraska retail pharmacies as of May 2026.

Brand-Name Rapamune

Pfizer's Rapamune (1 mg tablets) carries a wholesale acquisition cost (WAC) of approximately $950 for 100 tablets. Few off-label patients choose brand-name product at this price point. A Pfizer patient assistance program exists for transplant patients, but eligibility criteria typically exclude off-label use [1].

Nebraska Medicaid and Insurance Coverage

Nebraska Medicaid does not cover sirolimus for off-label longevity indications. Coverage is limited to the FDA-approved transplant rejection prophylaxis indication, and prior authorization is required even for that use [6].

Private Insurance

Most private insurers in Nebraska (Blue Cross Blue Shield of Nebraska, Medica, UnitedHealthcare) also restrict sirolimus coverage to the transplant indication. Some plans may cover it for lymphangioleiomyomatosis (LAM), which received an FDA-approved indication in 2015. Off-label longevity use is almost universally excluded from formulary coverage.

Prior Authorization for Transplant Use

For patients who do need sirolimus for transplant rejection, Nebraska Medicaid requires the following documentation: (1) confirmation of organ transplant, (2) prescriber specialty (transplant medicine or nephrology), (3) prior and current immunosuppression regimen, and (4) documentation that the patient cannot use alternative agents such as tacrolimus or mycophenolate. Turnaround for prior authorization is typically 3 to 5 business days.

Timeline: Prescription to First Dose

The total time from initial consultation to receiving your first rapamycin dose depends on three variables: appointment availability, lab turnaround, and pharmacy compounding time.

Typical Timeline

| Step | Estimated Time | |---|---| | Schedule and complete telehealth visit | 1 to 3 days | | Lab draw and results | 2 to 4 business days | | Prescriber reviews labs, sends prescription | 1 to 2 business days | | Pharmacy compounds and ships | 5 to 10 business days | | Total | 9 to 19 business days |

Patients using a retail pharmacy for generic tablets instead of a compounding pharmacy can shave 3 to 7 days off this timeline, since retail pharmacies typically fill prescriptions within 1 to 2 business days.

Transferring a Rapamycin Prescription to Nebraska

If you already have an active sirolimus prescription from another state, a Nebraska-licensed pharmacy can accept a transferred prescription under standard interstate transfer rules. The originating pharmacy calls or electronically sends the transfer to the receiving Nebraska pharmacy. Your prescriber does not need to hold a Nebraska license for the transfer itself, but ongoing refills will require a Nebraska-licensed prescriber to write new prescriptions once the transferred fills are exhausted.

Limitations

Compounded medication prescriptions are sometimes non-transferable depending on the originating state's regulations. If your current prescription is from a 503A pharmacy in, say, Colorado, you may need a new prescription written by your Nebraska telehealth provider directed to a Nebraska 503A pharmacy.

Safety Considerations and Monitoring

Low-dose weekly rapamycin has a different side-effect profile than daily transplant dosing. The PEARL trial (N=150) reported the most common adverse events at 5 mg weekly as canker sores (18%), upper respiratory symptoms (12%), and acne-like skin changes (8%) [2]. Serious adverse events occurred at similar rates in the rapamycin and placebo groups.

When to Contact Your Prescriber

Contact your prescriber promptly if you develop persistent mouth ulcers, fever above 101°F, unexplained bruising, or a fasting lipid panel showing LDL above 190 mg/dL. Dr. Matt Kaeberlein, a prominent rapamycin researcher at the University of Washington, has stated: "The risk-benefit calculation for off-label rapamycin hinges on monitoring. Unmonitored use is where problems occur" [7].

Drug Interactions

Sirolimus is metabolized by CYP3A4 and is a substrate of P-glycoprotein. Strong CYP3A4 inhibitors (ketoconazole, itraconazole, clarithromycin, grapefruit juice) can dramatically increase sirolimus levels. Strong CYP3A4 inducers (rifampin, phenytoin, carbamazepine) can reduce efficacy. The FDA label recommends avoiding concomitant use with strong CYP3A4 inhibitors or, if unavoidable, reducing the sirolimus dose and monitoring trough levels [1].

Frequently Asked Questions